Reduction in the levels of inflammatory cytokines (IL-6, TNF-α and LPS); reduction in obesity-associated systematic inflammation and endotoxemia. Increase in Bacteroides/Firmicutes ratio; reduction in pathogenic bacteria load; increase in short-chain fatty acid (SCFA)-producing bacteria. The gene discussed is TNF; the disease is serum lipopolysaccharide activity.